Cannabics Pharmaceuticals Announces a New Dosage of 5mg THC Cannabis Capsule Treating Cancer Patients Suffering from Cachexia and Anorexia Syndrome

BETHESDA, Maryland, Jan. 3, 2017 /PRNewswire/ Cannabics Pharmaceuticals Inc. (CNBX) today announced development of Cannabics 5mg THC Capsule intended for naïve patient who have not tried cannabis in the past. Dr. Eyal Ballan, Chief scientist of Cannabics Pharmaceuticals stated, Our mission is to find the right balance between efficacy on the one hand and the elimination of undesired psychoactive effects on other. The Cannabics 5mg THC capsule is currently being evaluated by the company in a clinical study as
http://bit.ly/2hMXv0P